Phenylephrine topical gel (PSD503) / Regent Pacific Group - LARVOL DELTA

Pharmacotherapy in Stress Urinary Incontinence; A Literature Review. (PubMed, Curr Urol Rep) - "One trial showed reduced pad weight gain with PSD-503, a locally administered α-adrenergic receptor agonist. Currently, trials are evaluating novel targets. Systemic adverse effects such as gastrointestinal upset with duloxetine and orthostatic hypotension with α-adrenoceptor agonists have hampered the efficacy of drugs used to treat SUI in women and men."

Journal • Review • Gastrointestinal Disorder • Hypotension • Urinary Incontinence • Urology